Study protocol for a randomised, double-blind, placebo-controlled 12-week pilot phase II trial of Sailuotong (SLT) for cognitive function in older adults with mild cognitive impairment.
Genevieve Zara SteinerAlan BensoussanJianxun LiuMark I HohenbergDennis H ChangPublished in: Trials (2018)
Australian New Zealand Clinical Trials Registry (ANZCTR), ACTRN12617000371392 Registered on 10 March 2017.